On December 5, 1996, Sucampo Pharmaceuticals, Inc. was incorporated in the state of Delaware.
Sucampo is headquartered at805 King Farm Boulevard, Suite 550, Rockville, Maryland 20850.
Sucampo’s initial public offering occurred on August 2, 2007, with 3,750,000 class A common stock shares sold at a price of $11.50 per share.
As of March 31, 2015, Sucampo employed approximately 84 employees in three continents.
American Stock Transfer & Trust LLC, 6201 15th Avenue, Brooklyn, NY 11219.
Ernst & Young, LLP
Sucampo runs on a calendar year with the fiscal year ending on December 31.
Our class A common stock has been approved for quotation on the NASDAQ Global Market under the symbol “SCMP.”
Sucampo does not currently pay a dividend.